| 中晚期肝癌介入化疗术的预后影响因素 |
| |
| 引用本文： | 南克俊,隋晨光,魏永长,李春丽,李毅,杨谨,陈玲,刘亚民. 中晚期肝癌介入化疗术的预后影响因素[J]. 医学争鸣, 2002, 23(12): 1134-1136 |
| |
| 作者姓名： | 南克俊 隋晨光 魏永长 李春丽 李毅 杨谨 陈玲 刘亚民 |
| |
| 作者单位： | 1. 西安交通大学第一医院:肿瘤内科,陕西,西安,710061
2. 西安交通大学第一医院:医学影像中心,陕西,西安,710061 |
| |
| 摘 要： | 目的：探讨中晚期肝癌介入化疗后的主要预后影响因素。方法：对81例行介入化疗的中晚期肝癌病例进行回顾性统计，应用COX比例风险模型对14项指标进行了多因素分析，并用Kaplan-Meier法计算其生存率。结果：多变量分析显示，影响中晚期肝癌预后最明显的因素是肿瘤大体类型、门静脉癌栓、经手术治疗；经肝动脉插管灌注化疗组与经肝动脉插管化疗栓塞组的预后无差异。本组6，12，24，30mo生存率分别为58％，32％，15％，12％。结论：中晚期肝癌预后由多种因素决定。对于肿瘤相对局限、无门静脉癌栓的患者积极行介入化疗术，可获得较好的疗效。
|
| 关 键 词： | 肝细胞癌 导管插入术 动脉内输注 化学栓塞治疗 预后 |
| 文章编号： | 1000-2790(2002)12-1134-03 |
| 修稿时间： | 2001-12-28 |
Prognostic factors in patients with advanced hepatocellular cancer after transcatheter arterial chemo-embolization |
| |
| NAN Ke Jun ,SUI Cheng Guang ,WEI Yong Chang ,LI Chun Li ,LI Yi ,YANG Jin ,CHEN Ling ,LIU Ya Min. Prognostic factors in patients with advanced hepatocellular cancer after transcatheter arterial chemo-embolization[J]. Negative, 2002, 23(12): 1134-1136 |
| |
| Authors: | NAN Ke Jun SUI Cheng Guang WEI Yong Chang LI Chun Li LI Yi YANG Jin CHEN Ling LIU Ya Min |
| |
| Affiliation: | NAN Ke Jun 1,SUI Cheng Guang 1,WEI Yong Chang 1,LI Chun Li 1,LI Yi 1,YANG Jin 1,CHEN Ling 1,LIU Ya Min 2 1Department of Oncology,2Medical Imaging Center,First Hospital,Xi'an Jiaotong University,Xi'an 710061,China |
| |
| Abstract: | AIM To evaluate the major prognostic factors in advanced hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) and transcatheter arterial infusion chemotherapy (TAI). METHODS Retrospective analysis of 14 factors for prognosis were studied by multivariable analysis with COX proportional hazards survival model in cases of HCC treated by interventional chemotherapy via hepatic artery, and the survival rate was calculated by Kaplan Meier estimation. RESULTS Multivariable analyses revealed significant prognostic factors as follows: tumor gross type, tumor thrombus in the portal vein and subsequent to redical resection. In this series, the survival rate of 6, 12, 24, 30 mon were 58%, 32%, 15%, and 12% respectively. Survival of patients with TACE was similar to that with TAI. CONCLUSION The prognosis of HCC is determined by various factors. For patients with massive form and no tumor thrombus in the portal vein, TACE and TAI are strongly recommended so as to improve the prognosis. |
| |
| Keywords: | carcinoma hepatocellular catheterization peripheral infusions intra arterial chemoembolization therapeutic prognosis |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
